Oncolytics Biotech (TSE:ONC) has released an update.
Oncolytics Biotech Inc. reported a decrease in cash and cash equivalents from CAD 34,912 thousand as of December 31, 2023, to CAD 24,850 thousand by June 30, 2024, according to its latest unaudited financial statements. Total assets decreased over the same period from CAD 38,820 thousand to CAD 32,069 thousand, with a corresponding decline in shareholders’ equity from CAD 27,563 thousand to CAD 18,311 thousand.
For further insights into TSE:ONC stock, check out TipRanks’ Stock Analysis page.
